| 221/297 | US=29 / Gastro Dias MGM, Dani R, Lima EJM. Miscelânea: farmacoterapia, aparelho digestivo e o paciente geriátrico. In: Dani R. Gastroenterologia essencial. 3ª ed. Rio de Janeiro: Guanabara Kogan, 2006. p. 1064-74. ISBN 85-277-1131-1. TRATO GASTROINTESTINAL; DOENCAS SISTEMICAS; TERAPIA MEDICAMENTOSA; EFEITOS COLATERAIS; ANALGESICOS; DROGAS ANTI-HIPERTENSIVAS; DROGAS HIPOLIPEMIANTES; DROGAS ANTIARRITMICAS; ANTAGONISTAS DOS RECEPTORES ADRENERGICOS ALFA-1 POS-SINAPTICOS; SEDATIVOS HIPNOTICOS; BENZODIAZEPINICOS; BARBITURICOS; ANTIDEPRESSIVOS; ANTIPSICOTICOS; DROGAS HIPOGLICEMIANTES; DROGAS ANTICOAGULANTES; CORTICOSTEROIDES; ANTIBIOTICOS; ANTINEOPLASICOS; DROGAS ANTIINFLAMATORIAS NAO-ESTEROIDES; ANTIACIDOS; ANTAGONISTAS DOS RECEPTORES H2 DA HISTAMINA; INIBIDORES DE BOMBA PROTONICA; SUCRALFATO; DROGAS ANTICOLINERGICAS; AGENTES PROCINETICOS; LAXATIVO; ANTIDIARREICO |
| 222/297 | US=14 / Urologia Hernandez J, Thompson IM Jr. Prostate cancer: prevention of prostate cancer. In: Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM. Comprehensive textbook of genitourinary oncology. 3ª ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 79-85. ISBN 978-0-7817-4984-0. CANCER DE PROSTATA. PREVENCAO; MANIPULACAO HORMONAL; INIBIDORES DE CICLOOXIGENASE-2; DROGAS ANTIINFLAMATORIAS NAO-ESTEROIDES; ANTIOXIDANTES; ENSAIOS CLINICOS; INTERVENCAO DIETETICA |
| 223/297 | US=14 / Urologia Cote RJ, Lerner SP, Datar RH. Bladder and upper tract cancer: molecula biology and prognostic markers in bladder cancer. In: Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM. Comprehensive textbook of genitourinary oncology. 3ª ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 385-401. ISBN 978-0-7817-4984-0. BEXIGA; CANCER DO TRATO SUPERIOR; BIOLOGIA MOLECULAR; MARCADORES PROGNOSTICOS; CANCER DE BEXIGA; VIA P53; GENE RETINOBLASTOMA; CICLINAS; QUINASES DEPENDENTES DA CICLINA; INIBIDORES DE CDK; ANGIOGENESE; RECEPTORES DO FATOR DE CRESCIMENTO; METILACAO DO DNA |
| 224/297 | US=14 / Urologia Stadler WM. Kidney cancer: chemotherapy and other approaches in the management of metastatic renal cell carcinoma. In: Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM. Comprehensive textbook of genitourinary oncology. 3ª ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 796-804. ISBN 978-0-7817-4984-0. CANCER DE RIM; QUIMIOTERAPIA; CARCINOMA DE CELULAS RENAIS METASTATICO. TERAPIA; TERAPIA CITOTOXICA; TERAPIA HORMONAL; INIBIDORES DE TIROSINA-QUINASES; ANTIANGIOGENICOS; AGENTES ALVOS ESTROMAIS; METASTASE |
| 225/297 | US=47 / Clín/Medica Hong Y, Chen S. Aromatase inhibitors: structural features and biochemical characterization. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 237-51. ISBN 978-1-57331-699-5. INIBIDORES DA AROMATASE; CANCER DE MAMA; INIBIDORES DE AROMATASE; FLAVONOIDE FITOESTROGENO; INIBIDOR BASEADO NO MECANISMO; MODELO STRCTURAL |
| 226/297 | US=49-A / Câncer Sharp S, Workman P. Inhibitors of the HSP90 molecular chaperone: current status. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2006. p. 323-48. ISBN 978-0-12-006695-7. |
| 227/297 | US=5 / UTI Lasmar MF, Guimarães HP. Cardiovascular: drogas vasoativas. In: Falcão LFR, Guimarães HP, Amaral JLG. Medicina intensiva para graduação. São Paulo: Atheneu, 2006. p. 159-65. ISBN 85-7379-833-5. UTI; DROGAS VASOATIVAS; CHOQUE SEPTICO; CATECOLAMINA; DOPAMINA; DOBUTAMINA; NORADRENALINA; ADRENALINA; ISOPROTERENOL; DOPEXAMINA; FENILEFRINA; VASOPRESSINA; INIBIDORES DA FOSFODIESTERASE |
| 228/297 | US=61 / Biol/Mol Rodrigues JJS, Silva RC, Siqueira MM. Técnicas de biologia molecular aplicadas ao diagnóstico. In: Rossetti ML, Silva CMD, Rodrigues JJS. Doenças infecciosas: diagnóstico molecular. Rio de Janeiro: Guanabara-Koogan, 2006. p. 16-40. ISBN 85-2771083-8. REACAO EM CADEIA DA POLIMERASE; PCR HOT START; PCR TOUCH-DOWN; PCR MULTIPLEX; NESTED PCR; RT-PCR; IONS DE MAGNESIO; DESOXIRRIBONUCLEOSIDEOS TRIFOSFATADOS; PRIMERS; DNA-MOLDE; INIBIDORES DE PCR; EXTRACAO DE ACIDOS NUCLEICOS; OBTENCAO DE RNA; ELETROFORESE DE DNA; ENZIMAS DE RESTRICAO; TECNICA; RFLP; HIBRIDIZACAO DE ACIDOS NUCLEICOS; IMOBILIZACAO DE ACIDOS NUCLEICOS; CLONAGEM MOLECULAR; SEQUENCIAMENTO DE DNA |
| 229/297 | US=61 / Câncer Sledge Junior GW, Miller KD, Schneider B, Sweeney CJ. Biochemical resistance: resistance to to antiangiogenic agents. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 391-410. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. ANTIANGIOGENESIS; FACTORES DE CRESCIMENTO ENDOTELIAIS VASCULARES; RECEPTOR DO FATOR ENDOTELIAL VASCULAR; HIPOXIA; INIBIDORES DA TIROSINA QUINASE |
| 230/297 | US=61 / Câncer osipo C, O'Regan RM. The role of hormones, growth factors, and oncogenes: resistance to antiestrogens. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 411-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. ANTIESTROGENEO; RESISTENCIA; TAMOXIFEN; CANCER DE MAMA; RECEPTOR DE ESTROGENO; INIBIDORES DE AROMATASE; FACTORES DE CRESCIMENTO |
| 231/297 | US=8 / Quimioterapia Pommier Y, Goldwasser F. Topoisomerase II inhibitors: the epipodophyllotoxins, acridines, and ellipticines. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 451-75. ISBN 978-0-7817-5628-6. INIBIDORES DA TOPOISOMERASE II; EPIPODOFILOTOXINAS; ACRIDINAS; ELIPTICINAS; FARMACOLOGIA MOLECULAR; FARMACOLOGIA CELULAR; FARMACOLOGIA CLINICA |
| 232/297 | US=8 / Quimioterapia Colevas AD, Scharf O, Vereshchagina LA, Dancey JE, Ivy SP, Neckers L, Kaufman B, Swerdlow R. New targets for anticancer therapeutics. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 549-78. ISBN 978-0-7817-5628-6. TERAPIA ANTICANCER; INIBIDORES DE QUINASES DEPENDENTES DE CICLINA; SB-715992; MEDI-522; VITAXINA; EMD 121974; CILENGITIDE; RAPAMICINA; ALILAMINOGELDANAMICINA; DIMETILAMINOETILAMINO; DEMETOXIGELDANAMICINA |
| 233/297 | US=8 / Quimioterapia Zakarija A, Gradishar WJ. Inhibitors of tumor angiogenesis. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 605-20. ISBN 978-0-7817-5628-6. INIBIDORES DA ANGIOGENESE TUMORAL; INIBIDORES DE METALOPROTEINASE DE MATRIZ; INIBIDORES DAS CELULAS ENDOTELIAIS |
| 234/297 | US=8 / Quimioterapia O'Connor OA. Proteasome inhibitors. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 621-40. ISBN 978-0-7817-5628-6. INIBIDORES DE PROTEASSOMA; QUIMICA; MECANISMOS DE ACAO; FARMACOLOGIA |
| 235/297 | US=8 / Quimioterapia Clark JW. Molecular targeted drugs and growth factor receptor inhibitors. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 641-65. ISBN 978-0-7817-5628-6. CANCER. TERAPIA; DROGAS ESPECIFICAS; INIBIDORES DO RECEPTOR DO FATOR DE CRESCIMENTO; ANTICORPOS MONOCLONAIS; IMATINIBA; GEFITINIBA; ERLOTINIBA; OLIGONUCLEOTIDOS ANTI-SENTIDO; TERAPIA GENICA |
| 236/297 | US=8 / Quimioterapia Lebowitz PF, Swain SM. Hormonal therapy for breast cancer. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 809-46. ISBN 978-0-7817-5628-6. CANCER DE MAMA; TERAPIA HORMONAL; ESTROGENO. ESTRUTURA; ESTROGENO. BIOSSINTESE; ESTROGENO. TRANSPORTE; ESTROGENO. METABOLISMO; RECEPTOR DE ESTROGENO; ESTROGENO. TERAPIA; TAMOXIFENO; FULVESTRANTE; INIBIDORES AROMATASE; PROGESTINA; RESISTENCIA HORMONAL |
| 237/297 | US=21 / Cab/Pesc Saba NF, Khuri FR. Chemopreventio in head and neck cancer. In: Adelstein JD. Squamous cell head and neck cancer: recent clinical progress and prospects for the future. Totowa: Humana Press, 2005. p. 279-303. ISBN 1-58829473-0. NEOPLASIAS DE CABECA E PESCOCO; CARCINOMA DE CELULAS ESCAMOSAS; QUIMIOPREVENCAO; CARCINOGENESE; ANTAGONISTAS & INIBIDORES |
| 238/297 | US=16 / Tórax Dowell J, Gazdar AF, Shigematsu H, Herz J, Minna JD. Lung cancer biology: clinical and biologic implications of EGFR mutations in lung cancer. In: Pass HL, Carbone DP, Johnson DH, Minna JD, Turrisi III AT. Lung Cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 172-7. ISBN 0-7817-4620-5. ONCOGENE; MUTACOES EGFR; NEOPLASIA PULMONAR; RECEPTOR DE TIROSINA QUINASE; INIBIDORES DE TIROSINA QUINASE; MUTACAO DE TIROSINA QUINASE |
| 239/297 | US=16 / Tórax Onn A, Isobe T, Herbst RS. Novel therapeutic strategies: antiangiogenesis therapy in lung cancer. In: Pass HL, Carbone DP, Johnson DH, Minna JD, Turrisi III AT. Lung Cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 713-24. ISBN 0-7817-4620-5. INIBIDORES DA ANGIOGENESE; NEOPLASIA PULMONAR; AGENTES ANTI-VASCULARES; TERAPIA ANTI-VASCULAR |
| 240/297 | US=16 / Tórax Laskin J, Johnson DH. Novel therapeutic strategies: receptor tyrosine kinase inhibitors. In: Pass HL, Carbone DP, Johnson DH, Minna JD, Turrisi III AT. Lung Cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 725-33. ISBN 0-7817-4620-5. RECEPTORES DA FAMILIA EPH; INIBIDORES DE TIROSINA QUINASE; GENES ERBB-1; TERAPIA COMBINADA |